New implant aims to restore erections after prostate cancer surgery
Disease control
Recruiting now
This study tests a new device implanted during prostate surgery to help men regain erectile function. Twenty men aged 30-75 with early-stage prostate cancer will be enrolled. The device is activated daily, and participants will be monitored for safety, side effects, and satisfact…
Phase: NA • Sponsor: Comphya Inc. • Aim: Disease control
Last updated May 17, 2026 03:40 UTC